Glucagon-Like Peptide-1 Receptor Agonists and Alcohol Use: A Real-Word Observational Study in a Large, Integrated Health Care System.

Results Both GLP1-RA–treated and untreated groups reduced their drinks/week from baseline to follow-up (mean change [95% CI] = −1.81 [−2.11 to −1.51] and −1.38 [−1.70 to −1.06], respectively); the group difference did not reach statistical significance (D-I-D [95% CI] = −0.43 [−0.87 to 0.01]).

also in 111,027 other papers